468 Participants Needed

Resilience Training for Age-related Cognitive Decline

(MEDEX-2 Trial)

Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: Washington University School of Medicine
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of this treatment for age-related cognitive decline?

Research shows that Mindfulness-Based Stress Reduction (MBSR) and exercise programs can improve health and well-being, and they have been effective in reducing anxiety and depression in cancer patients. These components may also help with age-related cognitive decline by promoting mental and physical health.12345

Is Mindfulness-Based Stress Reduction (MBSR) safe for humans?

Mindfulness-Based Stress Reduction (MBSR) is generally considered safe for humans and has been used to help with stress, anxiety, depression, and various chronic illnesses. It is a meditation program that has been adapted for different settings, including healthcare staff, and is recommended for its mental health benefits.15678

How does the Resilience Training for Age-related Cognitive Decline treatment differ from other treatments for cognitive decline?

This treatment is unique because it combines physical exercise, health education, and mindfulness-based stress reduction, which together may enhance both physical and cognitive resilience in older adults. Unlike standard treatments that might focus on medication or single interventions, this approach integrates multiple activities to potentially improve overall brain health and delay cognitive decline.910111213

What is the purpose of this trial?

This project capitalizes on a natural experiment imposed by the COVID-19 pandemic in conjunction with an extensive set of cognitive, emotional, biological, and neuroimaging variables already collected at multiple time points in older adults participating in a clinical trial of exercise and mindfulness. This project will elucidate the effects of stress on cognitive function and emotional health in later life, including biological measures of Alzheimer Disease risk, stress, and aging, with the ultimate goal of discovering how to mitigate these effects, among older adults who have made and maintained a lifestyle change.

Research Team

Eric Lenze, M.D. - Psychiatry

Eric Lenze, MD

Principal Investigator

Washington University School of Medicine

Eligibility Criteria

This trial is for older adults who were part of a previous study (Protocol ID #201410093). They should be able to safely continue with classes and assessments. The focus is on those experiencing cognitive decline or stress related to the COVID-19 pandemic.

Inclusion Criteria

Participated in the parent study, Protocol ID #201410093

Exclusion Criteria

Inability to safely continue classes or complete assessments, as per PI discretion

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in exercise, health education, and mindfulness-based stress reduction activities, with monthly sessions and at-home practice

Approximately three years
Monthly sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Exercise
  • Health Education
  • Mindfulness-Based Stress Reduction
  • Mindfulness-Based Stress Reduction + Exercise
Trial Overview The study tests how health education, mindfulness-based stress reduction, exercise, and a combination of mindfulness plus exercise can impact brain health and resilience during the pandemic among older adults.
Participant Groups
4Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness-Based Stress Reduction + ExerciseExperimental Treatment1 Intervention
This condition will receive both MBSR and exercise as described. Participants in this condition will attend monthly sessions with encouragement to complete at-home mindfulness practice as well as at-home exercise for the duration of the study.
Group II: Mindfulness-Based Stress ReductionExperimental Treatment1 Intervention
Mindfulness-Based Stress Reduction (MBSR) as delivered in the parent study (Protocol ID #201410093) consisted of a brief introductory meeting, eight weekly 2.5-hour classes, and a retreat, followed by monthly booster sessions for approximately 15 months. Content included instruction in mindfulness meditation practices, gentle mindful movement, and exercises to enhance mindfulness in everyday life. For the current study, participants will continue monthly approximately 2.5 hour booster sessions covering similar content for the duration of the study. Participants will be encouraged to maintain daily formal meditative activities at home.
Group III: ExerciseExperimental Treatment1 Intervention
The exercise protocol in the parent study (Protocol ID #201410093) was optimal for improving aerobic fitness and insulin sensitivity in older adults, as well as improving strength and balance and reducing indices of frailty. It consisted of classes twice weekly for 6 months, building up to 1.5 hr, under the direct supervision of trained exercise instructors, followed by once weekly classes for 12 months. For the current study, participants will continue monthly approximately 1.5 hour classes focused on functional training for the duration of the study. Participants will be encouraged to continue between-session engagement in aerobic and resistance training activities at home.
Group IV: Health EducationActive Control1 Intervention
The health education control condition is based on a chronic disease self-management program developed at Stanford University and was used as an attentional control in the parent study (Protocol ID #201410093). This control intervention was designed to be time-equivalent to MBSR, with 8 weeks of 2.5 hour weekly group classes followed by monthly booster sessions for approximately 15 months. For the current study, participants will continue monthly approximately 1.5 hour sessions covering similar content for the duration of the study.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Washington University School of Medicine

Lead Sponsor

Trials
2,027
Recruited
2,353,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

University of California, San Diego

Collaborator

Trials
1,215
Recruited
1,593,000+

Findings from Research

In a study of 66 healthy adults, 8 weeks of aerobic exercise training (AET) significantly increased the time spent in moderate-to-vigorous physical activity (MVPA) compared to a no-treatment control, suggesting AET is effective for enhancing physical activity levels.
Mindfulness-based stress reduction (MBSR) training appeared to help mitigate the decrease in physical activity typically associated with shorter days and cooler weather, indicating its potential role in maintaining exercise participation during challenging seasonal conditions.
Benefits of 8-wk Mindfulness-based Stress Reduction or Aerobic Training on Seasonal Declines in Physical Activity.Meyer, JD., Torres, ER., Grabow, ML., et al.[2020]
This pilot study will involve 30 women with breast cancer, focusing on the integration of mindfulness and exercise over 8 weeks to assess its impact on anxiety, depression, quality of life, and PTSD symptoms.
If the initial results show significant benefits, the program may be refined and potentially lead to the creation of a Mindfulness-based Exercise Program Manual for broader use in supporting cancer patients.
Mindful exercise, quality of life, and survival: a mindfulness-based exercise program for women with breast cancer.Tacón, AM., McComb, J.[2015]
Mindfulness-Based Stress Reduction (MBSR) therapy significantly improved anxiety and depression scores in 106 breast cancer patients undergoing postoperative chemotherapy compared to a control group of 111 patients receiving routine nursing.
The MBSR intervention positively impacted the overall quality of life, particularly in psychological aspects, although it did not show significant effects on physiological health.
Research on Mindfulness-Based Stress Reduction in Breast Cancer Patients Undergoing Chemotherapy: An Observational Pilot Study.Wang, H., Yang, Y., Zhang, X., et al.[2023]

References

Benefits of 8-wk Mindfulness-based Stress Reduction or Aerobic Training on Seasonal Declines in Physical Activity. [2020]
Mindful exercise, quality of life, and survival: a mindfulness-based exercise program for women with breast cancer. [2015]
Research on Mindfulness-Based Stress Reduction in Breast Cancer Patients Undergoing Chemotherapy: An Observational Pilot Study. [2023]
Mindfulness-based stress reduction and cancer: a meta-analysis. [2022]
Mindfulness-Based Stress Reduction for Health Care Staff: Expanding Holistic Nursing Paradigms to the Whole System. [2021]
[Effect of mindfulness on symptoms of stress, anxiety and depression]. [2019]
No sustained attention differences in a longitudinal randomized trial comparing mindfulness based stress reduction versus active control. [2022]
Mindfulness-based stress reduction: a non-pharmacological approach for chronic illnesses. [2022]
Exercise level and cognitive decline: the MoVIES project. [2022]
The impact of exercise on the cognitive functioning of healthy older adults: a systematic review and meta-analysis. [2022]
11.United Statespubmed.ncbi.nlm.nih.gov
Physical and cognitive activity and exercise for older adults: a review. [2017]
Can exercise prevent cognitive decline? [2022]
13.United Statespubmed.ncbi.nlm.nih.gov
From bedside to bench: does mental and physical activity promote cognitive vitality in late life? [2006]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security